TCS inhibited expression of PPARγ target genes related to cell vitality, migration, and angiogenesis via PPARγ pathway in vitro. (A,B) The mRNA expression was analyzed by RT-PCR exposed to the indicated dose of TCS in HTR-8/SVneo and JEG-3 cells. (C,D) HTR-8/SVneo and JEG-3 cells treated with or without rosiglitazone and GW9662 for 24 h in HTR-8/SVneo and JEG-3 cells exposed to TCS (40 µM for HTR-8/SVneo, 30 µM for JEG-3). (E–H) PPARγ was overexpressed (E,F) or displayed knockdown (G,H) and co-treated with TCS in HTR-8/SVneo and JEG-3 cells. (I,J) The protein expression of ANGPTL4 (I) and MMP-2 (J) was analyzed by Western blot in HTR-8/SVneo and JEG-3 cells exposed to TCS. The relative values of protein expression are shown below. The data are shown as the means ± S.E.M. * p < 0.05; ** p < 0.01; compared with the indicated group, n = 3.